Post Show Report · pharmaceutical exhibition with hundreds of conferences and activities held onsite, shows the latest development trends and advanced technologies in global pharmaceutical

www.cphi.com/china www.cphi.com/p-mec-china

Post Show Report

Asia's leading trade & networking platform covering the entire pharma industry chain

Concurrently held with:

June 20-22, 2018 Shanghai New Int'l Expo Centre (SNIEC)

2019

1

3

6

9

10

15

16

Contents

Show Profiles

2nd China Pharma Week

Visitors: 2018 Facts & Figures

Exhibitors: 2018 Facts & Figures

2018 Onsite Conferences & Activities

From Online to Offline

Photo Gallery & 2019 Outlook

Organised by UBM EMEA in collaboration with China Chamber of Commerce for Impor t & Expor t of Medicines & Health Products and co-organised by Shanghai UBM Sinoexpo International Exhibition Co, CPhI and its co-located events – ICSE, NEX, BioPh China, P-MEC, InnoPack and LABWorld China – concluded successfully at Shanghai New International Expo Centre on June 22.

Advancing continuously over the past 18 years, CPhI & P-MEC China has not only set up a giant international platform for China's pharmaceutical industry, but also witnessed the country's huge development in the 40 years of pharmaceutical reform from meeting the drug

Getting Access to the Entire Pharma Supply Chain Under One Roof

Building a Global Leading Pharmaceutical Industry Platform

demands in China to opening overseas mainstream markets. Hitting new records again in 2018, the show scale of CPhI & P-MEC China reached 180,000m2, while the exhibitor number reached 3,022 and the total number of visits 60,744, growing by 10% since 2017. The number of international visitors has increased massively reaching 15,329 – over 50% more visits from abroad than in 2017.

CPhI & P-MEC China, the leading pharmaceutical trade show in China and wider Asian - Pacific region, will make a big comeback on June 18-20, 2019 at SNIEC to offer again an international-level and high-quality pharmaceutical trade fair.

Record-Breaking Numbers in All Areas

3,022Total Exhibitors

15,329Overseas Number of Visits

60,744Total Visits

180,000 Exhibition Area (Square Meter)

APIsFine Chemicals &

Intermediates

Excipients & Formulation

AnimalHealth

CMO & CRO

Natural Extracts

Biopharmaceuticals

Packaging Materials

PharmaLogistics

Environmental Protection & Clean

Technology

Laboratory Equipment

Pharmaceutical Machinery

FDF

2 3

Name List ofOpening Ceremony

Mr. Zhou Hui, President of China Chamber of Commerce for Import & Export of Medicines & Health Products

Mr. Jime Essink, CEO of UBM Asia

Mr. Zhang Wei，Secretary General of Chinese Pharmacopoeia Commission

Mr. John van der Valk，Managing Director of UBM EMEA

Mr. Xu Xingfeng, Deputy Special Commissioner of Shanghai Special Commissioner's Office of Ministry of Commerce of China

Mr. Jerome Lepeintre，Minister Counsellor for Health and Consumers, Delegation of the European Commission in Beijing

Mr. Wang Qiang, Chairman of the board of Donghao Lansheng (Group) Co. Ltd.

Mr. Alexey Alekhin，Head of Department of pharmaceutical and medical industry development，Ministry of Industry and Trade of the Russian Federation

Mr. Gao Zhiqiang, Director of China International Import Expo Bureau

Mr. Mazin M. AL Ismaiel，Executive Director of Public Relations，Saudi Food Drug Authority

Mrs. Caroline Larsen Le Tarnec，Head of Public Relations & Documentation Division，European Directorate for the Quality of Medicines & HealthCare (EDQM, Council of Europe)

Mr. Hideo Tsunoda, Chairman of Japan Pharmaceutical Traders' Association

Mr. Oh Jang Suk, Chairman of Korea Pharmaceutical Traders Association

Mrs. Kang Wei, Managing Director of China Association of Enterpr i ses wi th Fore ign Investment , R&D -based Pharmaceutical Association Committee

Mrs. Zhu lihong, Senior Vice President and Managing Director, DIA Greater China

Gathering Industry Leaders, Establishinga New Chapter of the Pharmaceutical Industry

Themed by how to guarantee the balance and stability of

API supply chain, the summit invited leaders of representative

enterprises in the industry to a round table discussion. They

shared successful experiences and advice to address the above

challenges, providing insight into how to resolve the current

development predicament that enterprises are facing.

CPhI Networking DinnerThe networking dinner took place on the evening of June 20th

at the Bund. 200 government officials, Chinese and overseas

VIP buyers and pharmaceutical company executives shared

insights with industry peers from all over the world. They

broadened the high-end connections in the industry while

enjoying the night view of Huangpu River and tasting the

dinner delicacies.

The 9th China-World CEO Summit

2nd “China Pharma Week” inherits its high quality

The 5-day China Pharma Week was launched in Shanghai and surrounding areas in 2018 with 20 extended events to cover the Leadership, Business, Networking, Recognition, Knowledge, and Innovation of the pharmaceutical industry.

The conferences cover a wide range of topics, including analysis of Chinese and international pharmaceutical laws, regulations and new policies, interpretation of latest patents and intellectual property, green process transformation, etc., and the events were diversified, from the heavyweight industry awards, women in leadership forum to factory visit, and C-level networking dinner etc., to build an annual high-end pharmaceutical industry event that integrates trade, socializing, and knowledge sharing.

4 5

CPhI Women in Leadership Forum

The 2018 Award for Top 100 Internationalized Companies

The forum was successfully held at Le Sun Chine one night

before the show, to unveil the China Pharma Week. Themed by

"new era, new women, new health", the forum gathered over

60 women leaders of the pharma industry to share life insights

and talk about experience in the workplace.

Excellent Suppliers and Partners in International Market (Top

60), Leading Formulation Suppliers (Top 20), and Promising

Enterprises (Top 20) were selected on the basis of product export,

international registration, overseas M&A, and international

cooperation, etc. The lists were released before the show, and

published to all exhibitors and visitors on-site.

CPhI China International Business Programme

Plant Visit

Featuring two tracks, the International Business Programme

was developed with both domestic and international visitors

in mind. The sessions addressed the key trends, topics and

developments for international partners looking to expand to

or within the Chinese market and domestic partners looking

to grow operations outside of China or draw learnings from

international partners.

The Plant Visit continued the splendidness of the show after

closing on June 22nd. The organiser orchestrated 3 routes:

Cutting-edge System & Engineering, Scientific & Innovative

Instruments, and Amino Acid Manufacturing, leading nearly

40 professional visitors to the plant, which facilitated potential

partners to get in touch with the culture and technology of

suppliers closely, and feel the strength of 'Made in China'.

Exhibitor Testimonials

CPhI Shanghai is a must to attend if you have anything to do with China related pharma

business. It is not only for the raw materials but also provides great candidates for sales

operations and other areas like packages, CMO and machinery. Highly recommended!

Petri Karvinen, Orion Pharma, Head of China Operations................................................................................................................CPhI is an awesome event where people working in the pharmaceutical industry can learn

more.

Gonzalo Macoco Tabarez, Gonzalo, R&D Manager................................................................................................................China is practically the pharmacy of the world, you will get the best prices and just a huge

number of products from China and from India. We are really meeting very good products

and very good companies.

Ameeta Michelle Panemanglor, Business Development Manager, S.M.H.P Marketing & Consultancy............................................................................................It's a great opportunity for me to meet all people coming to CPhI China, from

all over South East Asia, that's a great opportunity.

Philippe Maigrot, Global Pharma Channel Strategy Director, Dow Consumer Solutions

Visitor Testimonials

Here it's a good opportunity to find new collaboration, new suppliers, new partners, you can find everybody in this show.

Norberto Prestes, Director, Brazilian API Industry Association

It's very important to be here, to understand that the very quick development of this market, to understand also the culture of this market.

Tommaso Broia, Export Area Manager APAC, Bormioli PharmaIndustry Association

CPhI China is a great platform that connects with international and domestic market and broadens the industry chain. Our company finds more international partnerships and promotes our international brand awareness here.

Tan Jahong, Deputy GM, Huzhou Zhanwang Pharmaceutical Co., Ltd

6 7

2015-2018 Overseas Visits

Visitors: 2018 Facts & Figures

Top 15 Overseas Visiting Countries

Visitor Continent Breakdown

Canada

U.S.A.

Spain

Switzerland Italy

Iran

India

Australia

Philippines

Japan

South Korea

Bangladesh

Germany

Russia

Pakistan

Increase

Increase

Increase

Visitor Job Title & Purchasing Power Analysis

(The above data is based on the onsite and post show survey.)

Visitor Company Business Breakdown (Top 8) Visitor Interest Area (Top 8)

Nearly 50% of the visitors are decision

makers, gathering high-end pharmaceutical

business ecosystem.

Pharmaceutical Company

Pharmaceutical Marketing Company

New Drug R&D

Fine Chemical Manufacturing

Contract Manufacturing & Outsourcing

Environmental Protection & Clean Engineering

Food & Beverage, Health Food Company

Biotech Company

25.7%Purchasing Department

1.4%Other

21.0%Sales / Marketing Department

16.6%R&D Department

7.6%Foreign Trade

Department

6.4%QC/QA Department

6.2%Safety and

Environmental Protection

5.3%Production Department

4.3%Engineering Management

3.2%Administrative Management

1.8%Logistics Department 30.0%

Manager / Project Manager /Department Head

19.6%

President / Chairman /CEO / General Manager

18.7%

10.0%

9.5%

8.1%

7.7 %

7.1%

7.0%

6.6%

IngredientsCPhI

Finished Dosage Formulation

FDF

Excipients & Formulation

PackagingInnoPack

Natural ExtractNEX

BiopharmaceuticalsBioPh

Machinery, Equipment, Technology

P-MEC

Laboratory EquipmentLABWorld

66%

29%

27%

25%

24%

22%

20%

20%

8 9

Domestic Visitors by China Provinces

Well-Received by Visitors, Record-Breaking Satisfaction Rates

Visitors were highly satisfied with CPhI & P-MEC China 2018.

Henan HubeiGuangdong Shandong JiangsuAnhui

Hebei Beijing Zhejiang Shanghai

Visitors will continue to attend CPhI & P-MEC China.

Visitors would recommend CPhI & P-MEC China to co-workers and industry partners.

(Top 10 Provinces)

Exhibitors Highly-Satisfied with Onsite Visitor Numbers

of exhibitors will return to CPhI & P-MEC China in 2019

of exhibitors were satisfied with the 2018 event

of exhibitors will recommend it to co-workers and industry partners

Exhibitors: 2018 Facts & Figures

10 11

CPhI and P-MEC China, as a leading international

pharmaceutical exhibition with hundreds of conferences

and activities held onsite, shows the latest development

t r e n d s a n d a d v a n c e d t e c h n o l o g i e s i n g l o b a l

pharmaceutical industry. This year, it involved more than

200 industry experts and attracted over 4,000 attendees to

participate actively.

Various themed conferences and activities were designed

to fit into the relevant industry chain of the show, which

attracts more and more professionals from pharmaceutical

engineering, QC/QA, certification, R&D and supply chain

department etc. as well as officials from supervision

Various Extended Onsite Conferences & Activities

department and experts from research institutes and

colleges and promotes multi-faced exchange and

integration.

The onsite conferences cover a wide range of topics,

including analys i s of Chinese and internat ional

pharmaceutical laws, market analysis of key export

countries and experience sharing of overseas market

development etc. and the events were diversified, from the

heavyweight industry awards, C-level networking dinner

to plant visit and innovation tour. Various conferences and

activities well extended the exhibition, which facilitate

business negotiation and social networking for all pharma

professionals.

2018 Onsite Conferences

China-World Innovation and Development Forum

The speeches of the forum were focused on the policy and market which covered the pharmaceutical

industry development situation and policy trends, CFDA's latest reforms and influences thereof, analysis of

the import & export and internationalisation situation of Chinese pharmaceutical products, pharmaceutical

product patent protection, and market access and regulation, etc., to provide a high-level exchange

platform for Chinese and overseas pharmaceutical entrepreneurs, industry experts, and relevant

government departments, and offer keen insights and thorough analysis of the new environments and new

situations of development of the Chinese and overseas pharmaceutical industries from the perspective of

globalisation strategy.

- June 20-21, 2018-

CPhI International Agencies Updates and Q&A: Japan & China Session

Experts from China National Drug Administration, Chinese Pharmacopoeia Commission,

Center for Food and Drug Inspection of CFDA, Shanghai Municipal Food and Drug

Administration, Delegation of the European Union to China, World Health Organization,

U.S. Food and Drug Administration, European Directorate for the Quality of Medicines

& HealthCare, United States Pharmacopeia Convention, British Standards Institute and

Saudi Food and Drug Authority, etc. together with over 200 representatives from nearly

100 enterprises were present at the conference. The conference has been held for

consecutive years, inviting Chinese and overseas pharmacopoeia and drug regulation

agencies to share the recent dynamics of drug regulatory policies, laws and regulations

and help enterprises improve levels in product registration application and quality system

construction, which is not only a high-end, open, and sharing platform for Chinese

and overseas pharmaceutical industries to exchange on drug regulatory laws and

regulations, but also an important window for Chinese pharmaceutical industry to be

synonymous with international standards.

- June 20, 2018-

The 1st CHP-JP Joint Forum

was succes s f u l l y he ld

in Shanghai on June

2 1 b y C h i n e s e

P h a r m a c o p o e i a

C o m m i s s i o n a n d

Society of Japanese

P h a r m a c o p o e i a ,

w i t h o v e r 2 0 0

representatives from

the China National Drug

Administration, Ministry of

Health, Labour and Welfare

of Japan, Pharmaceuticals

and Medical Devices Agency

of Japan, Chinese Pharmacopoeia

Commission, National Institutes for Food

and Drug Control of China, and Chinese and Japanese institutions for

pharmaceutical product research, production, and control present.

- June 21, 2018-

CPhI International Agencies Updates and Q&A

China and India, the two major

countries developing rapidly in the

pharma industry, have attracted

w o r l d w i d e a t t e n t i o n . I n d i a i s

the world's largest producer of

generic drugs, known as the "world

pharmacy" while China possesses

the most complete supply system of

pharma industry chain. The organizer

invited industry leaders from the two

countries to discuss the cooperation

and competit ion of China-India

pharma industry from various aspects

and angles, introduce the overall

situation of China-India pharma

market, analyse the advantages of

China-India pharma industry and

the investment guidance of Indian

pharma industry.

P-MEC China Summit 2018

The P-MEC China Summit 2018 lasted

for three days (June 20-22) and

came to a successful conclusion,

where lively and detailed speeches

were given mainly focusing on

topics like “Rationality of Deviation

I n v e s t i g a t i o n a n d E f f e c t i v e

Management of CAPA”, “Technology

Transfer Requirements in MAH”,

and “ Lean Manufactu r ing o f

Pharmaceuticals: How to create

rea l compet i t i venes s t h rough

effective integration with QA/QC”,

with an audience of nearly 200

people and fantastic interactions

during the discussion to let wisdom

sparkle in the clash of ideas; i t

provided insiders with an excellent

platform for analysing policies and

regulations, discussing quality culture

development, qualif ication and

validation, and data integrity, and

showcasing the latest technologies.

- June 20-22, 2018-

- June 21, 2018-

The Cooperation-Competitionof China-India Pharma Industry

12 13

2018 Onsite Conferences

The International Summit for Pharmaceutical Packaging & Drug Delivery System

Drug Safety and Quality Management Forum 2018

As the competition in global pharmaceutical market grows, how to enhance drug efficacy faster

and more accurate and how to improve the patients' experience of taking medicines by improving

the way of drug delivery has become one of the focuses for pharmaceutical enterprises. The

summit kept fingers firmly on hot topics of overseas and

domestic pharmaceutical packaging industry and

discussed the policy trends and the new design and

technology of drug delivery of solid, oral and injection

preparations, which provides a great platform for more

than 200 delegations to communicate with international

pharmaceutical packaging experts.

Kicked off on June 21, the 5th China BioPh Outlook Summit, an important

conference of the biopharmaceutical industry, invited over 20 Chinese and

oversea senior pharmaceutical experts to form a luxury speaker lineup, from

well-known pharmaceutical enterprises like Amgen, Bayer, Roche, Henlius, WuXi

AppTec, and Simcere, and professional agencies like Shanghai Biopharmaceutics

Industry Association, Shanghai Drug Evaluation and Inspection Center, SAPA, and

RDPAC, to focus on analysis of Chinese and overseas biological drug markets and

policies, explore the R&D trends of innovative biological drugs, discuss the new

R&D trends of anti-cancer drugs, and share about the new developments of tumor

immunotherapy and other hot topics. Over 300 industry elites were present on site,

to "feel the pulse" for the future of China's biopharmaceuticals.

- June 20-22, 2018-

- June 21, 2018-

On June 20, experts from the government, drug regulators, Chinese and

overseas enterprises, and research institutes conducted heated discussions

and exchanges by following China's quality management system under the

new situation, tracking of the latest regulatory policies for pharmaceutical

product safety, exploration of drug safety detection and risk control, and

application of new biological technologies, etc. This forum enabled attendees

to see the development trends and bright prospects of China's bio-medicine

industry, and that the drug R&D will raise higher requirements for China's

laboratory instrument industry.

- June 20, 2018-

5th China BioPh Outlook Summit

The forum gathered an advisory group in the environmental policy field of China and an expert panel on

environmental equipment and technology, to discuss the application of the environmental protection

technology in the pharmaceutical industry under the New Normal, and bring interpretations of the

latest pharmaceutical environmental protection policies and green and environmental protection

application solutions.Furthermore, to respond to China’s call for green manufacturing, promote energy

conservation and emission reduction and clean production, resist violations of environmental laws

and regulations, and drive green transformation and upgrading and sustainable development of the

pharmaceutical industry, the “Pharmaceutical Industry Green Development Initiative” initiated by All-

China Environmental Federation, CCCMHPIE, and UBM Sinoexpo, and actively responded by North China

Pharmaceutical Group Corporation, Hangzhou Lanran Environmental Technology Co., Ltd., Asymchem

Laboratories (Tianjin) Co., Ltd., Yangtze River Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical

Co., Ltd., DSM Sinochem Pharmaceuticals Limited, Zhejiang Liuhe Engineering Technology Co., Ltd., Zhejiang

Guobang Pharmaceutical Co., Ltd., and Beijing Key Laboratory of Resource-Oriented Treatment of Industrial

Pollutants of University of Science and Technology Beijing was released to the whole industry, to call for performing

environmental responsibilities and keeping the commitment for green development.

- June 20, 2018-

China Pharma Environmental Forum

2018 Onsite Activities

NEX High Quality Suppliers Gallery

In recent years, the plant extracts industry has maintained rapid growth. How to stand out in many plant extracts enterprises has

not only become an urgent demand for them, but also the focus of the buyers. The organizer specifically set up a display area of

quality suppliers of natural extracts at Hall E4 No. A02 booth. It was to display quality suppliers of plant extracts and their products

which have been initiated by CCCMHPIE together with NSF, USP, SGS, and Intertek, offering the NEX visitors a well-prepared mini-

show.

2018 InnoLAB Salon brought together

cutting-edge information and popular

products in the pharmaceutical laboratory

field and focused on two characteristic

topics: Innovation of Chromatographic

Technology and Construction of Intelligent

Laboratory. The Salon also gathered many

of the world's leading laboratory solution

providers, which provides a

platform of deep knowledge-

s h a r i n g a n d a c c u r a t e

networking for R&D, testing

and QA/QC professionals,

helps the construction of

pharmaceutical laboratory

and advances the R&D of

instruments.

此次沙龙汇集了制药实验室领域前沿资讯及热点产品，聚焦两大特

色主题，包括“色谱技术创新”和“智能实验室建设”，并汇聚了

众多全球知名实验室解决方案提供商，为药厂研发、检 /QA/QC 人

员提供了一个深层次的知识共享与精准人脉构建平台，助力医药实

验室建设，推进仪器研发大步向前。

2018 Innolab Salon

14 15

2018 Onsite Activities

P-MEC Overseas Buyer Group

In order to help Chinese pharmaceutical machinery and

equipment to go aboard, the organiser specially invited

nearly 50 overseas pharmaceutical machinery buyers from

Russia, Ukraine, Netherlands, France, Pakistan and Nepal

etc. to the event together with several partners. Among

these buyers, 18 of them had one-on-one conversations

with Chinese pharmaceutical machinery suppliers. A

number of overseas buyers not only expressed the strong

interest of suppliers' products onsite, but also extended

further contact with the supplier after the exhibition.

Pharmaceutical Packaging & Drug Delivery System Innovation Gallery & Tour

Taking "Innovative Drug Delivery Solutions" and "Solid

Preparation Packaging Solutions" as the subjects, this year's

activity brought visitors quality products excelling at patient

compliance, durability and automation. The high quality of the

products and enthusiastic response from visitors once again

proved that innovation and humanized design are not only the

market positioning of InnoPack China, but also at the core of

drug packaging development.

Pharma Clean Technology Innovation Tour

The tour was led by Mr. Wang Hongzhou from Suzhou Mei Mate Information

Consulting Co., Ltd. Over 10 professional visitors from engineering

department, equipment technology department and purchasing

department of pharma companies were guided to the specific booth of

pharma clean solutions including automation equipment from Longxin

and purification equipment from Rongdaxing. They also visited Honghai,

a company with 2500 ton automatic extrusion production line, Yeshine, a

leading high-tech joint venture, DST, Swedish desiccant equipment Supplier,

and Foster Wheeler AG, an engineering contracting company. Visitors

exchanged deep views with experts in pharma clean solutions and gained

the latest pharma clean solution products and market development trends.

One-stop Purchasing Platform from Online to OfflineCPhI.CN Evokes the Digital Pharma Trend

Meet Industry Big Shots

“CPhIdea Hub” Live Broadcast

Over 30 industry experts interacted with onsite visitors in relation to the

pharmaceutical industry market development, technology trends, new

product advantages, and policy changes, etc. in the interview room

and they aired respective views.

China Pharma Connect

New Matchmaking Tool Facilitates Onsite

Meetings

A new pre-show matchmaking platform - China

Pharma Connect was tailor made for exhibitors and

visitors this year to help each other find potential

partners and arrange onsite meetings before the

show, which successfully facilitated over 8,043

meetings across 3 days.

Taking Advantage of Mobile Internet

“Pharmaceutical Online Marketing Seminar”

The Pharmaceutical Online Marketing Seminar was fully attended, where CPhI.

CN analysed how to accomplish online marketing from the shallower to the

deeper and layer by layer together with Toutiao, adSage, a leading digital

marketing service provider, and Weimob, a mobile socialising expert.

In addition, the 360°panoramic VR experience show gave a real

reproduction of brand images, products and services, etc. of the exhibitors,

to enable visitors to experience the brand’s services on-site without the

need to make arduous journeys. The “Brain Quest” provided over 5,000

pharmaceutical associated questions, which made visitors eager for trying

and linger on.

International Business Opportunities Near at Hand

8th CPhI Buyers Sourcing Event Successfully Held

The 8th CPhI Buyers Sourcing Service invited international buyers to

achieve zero-distance negotiations: 150 buyers participated, and 551

cooperation negotiations took place in 2 days, realising a super high

sourcing efficiency. Through one-to-one and face-to-face way of talk,

the service team helped China's suppliers build business relationship

with international buyers.

16 17

Onsite Photo GalleryCPhI & P-MEC China 2019 will be held at Shanghai New International Expo Centre on June 18-20. The show will cover all halls of Shanghai New International Expo Centre for the first time, and is expected to reach 200,000m2 and attract over 3,200 Chinese and overseas exhibitors and more than 70,000 visits by professional visitors from

over 120 countries and regions, to create the strongest lineup in its history, which is not to be missed!Delivering a high quality event which reflects perfectly the potential of the market has always been the aspiration of the organizers. The 2019 event layout will propose reshaped zones as a result of the industry trends and market

demand.

BioPh China will be upgraded to bioLIVE China and move to Hall W4. It will focus on life sciences, biotechnology and innovative drugs and build Asia's premier partnering platform covering the whole pharmaceutical industry chain from small to large molecule together with CPhI China.LABWorld China will be extended to Hall W5.NEX China will move to Hall E4 and Hall E5.PharmaExcipients China will move to Hall E3.Animal Health & Feed Zone will move to Hall E7.

Remaining true to the original aspiration and forging ahead over the 18 years, the organiser will adhere to the spirit of "be the best", live up to the trust, advance together with insiders and industry enterprises, and help with the construction of the new structure of pharmaceutical industry.

CPhI & P-MEC China 2019 Outlook: New Layout, New Start

2019 Event Overview

SNIEC

P-MEC

& LA

BWo

rldIne

rnatio

nal A

rea

Animal Health

North

South

East

花木路

bioLIVE

2019

CPhI & P-MEC China 2019June 18-20, 2019

See You in SNIEC, Shanghai, Pudong

www.cphi.com/chinawww.cphi.com/p-mec-china

UBM EMEAUBM EMEA | International Exhibitions | de Entree 73 Alpha Tower | 1100BH Amsterdam | The NetherlandsTel: +31 20 708 1605Fax: +31 20 36 32 616Contact: Dina [email protected]

CCCMHPIE12F,3# Bldg., Beijing INN, No 6Nanzhugan Hutong, Dongcheng Dist. Beijing100010, China,Tel: +86-10-5803 6296Fax: +86-10-5803 6319Contact: Ms. [email protected]

UBM Sinoexpo7-8/F., 355 Hong Qiao Rd.Shanghai 200030, ChinaTel: +86-21-3339 2250 / 2255Fax: +86-21-33250710Contact: Ms. Mao/Ms. [email protected]@ubmsinoexpo.com